期刊文献+

卵巢上皮性肿瘤中PTEN的表达及临床意义 被引量:2

Expression and significance of PTEN in ovarian epithelial neoplasms
原文传递
导出
摘要 目的探讨卵巢上皮性肿瘤中蛋白酪胺酸磷酸酶基因(PTEN)的表达及临床意义。方法采用免疫组织化学法检测PTEN在57例卵巢上皮性癌、20例卵巢良性上皮性肿瘤和10例正常卵巢组织标本中的表达。结果卵巢上皮性癌中PTEN的阳性表达率为38.6%,明显低于正常卵巢组织的100%及卵巢良性上皮性肿瘤的95.0%(P<0.05);PTEN的阳性表达率与卵巢上皮性癌的临床分期、病理分级呈负相关(P<0.05);浆液性卵巢癌中PTEN的阳性表达率为36.84%(14/38),而8例子宫内膜样卵巢癌中仅有1例表达PTEN。结论PTEN表达下调可能在卵巢上皮性癌的发生、发展中起重要作用,与子宫内膜样卵巢癌的发生关系尤为密切。 Objective To investigate the expression and significance of phosphatase and tensin (PTEN) in ovarian epithelial neoplasms. Methods The PTEN protein was detected in 57 samples of ovarian epithelial carcinomas, 20 samples of benign ovarian epithelial tumors and 10 normal ovarian issues by immunohistochemistry. Results The positive rate of PTEN expression was significantly lower in ovarian epithelial carcinomas( 38. 6 %) than that ( 100% ) in benign ovarian epithelial tumors and that (95.0%) in normal ovary tissues (P〈0.05). The level of positive expression of PTEN was negatively correlated with clinical stages and histological grades (P〈0. 05). The positive rate of PTEN expression in serous carcinoma was 36.84%, but only one of eight endometrioid ovarian cancers expressed PTEN. Conclusion Down-regulation of PTEN expression might play an important role in the oncogenesis of ovarian epithelial carcinomas. The negative expression of PTEN correlates closely with the oncogenesis of endometrioid ovarian cancer.
出处 《江苏医药》 CAS CSCD 北大核心 2009年第11期1258-1259,共2页 Jiangsu Medical Journal
关键词 卵巢肿瘤 蛋白酪胺酸磷酸酶基因 Ovarian neoplasms Phosphatase and tensin
  • 相关文献

参考文献5

  • 1李艳芳,王益夫.妇科肿瘤的基因变化[M]//曹泽毅.中华妇产科学.第2版.北京:人民卫生出版社,2007:1790-1792.
  • 2Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23. 3 that is mutated in multiple advanced cancers [J]. Nature Genetics, 1997,15(4) :356-362.
  • 3陈颖,郑华川,杨雪飞,赵雨杰,侯伟健,汪桂兰,辛彦.PTEN基因突变及mRNA表达与卵巢癌病理生物学特征的关系[J].中国肿瘤临床,2004,31(7):365-367. 被引量:18
  • 4Takei Y,Saga Y, Mizukami H, et al. Overexpression of PTEN in ovarian cancer cells suppresses i. p. dissemination and extends survival in mice~[J]. Mol Cancer Ther, Z008,7 (3) : 704- 711.
  • 5Lee S, Choi EJ,Jin C, et al. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line[J].Gynecologic Oncology, 2005,97 (1) : 26-34.

二级参考文献1

共引文献17

同被引文献14

  • 1吕庆杰,赵晓东,宋继谒,李晓晗,马颖,孟辉,姜卫国.卵巢癌PTEN基因失活机制的探讨[J].中华病理学杂志,2005,34(5):266-269. 被引量:15
  • 2乔玉环,程佳,郭瑞霞.卵巢上皮性癌组织中磷酸化蛋白激酶B和PTEN蛋白的表达及其意义[J].中华妇产科杂志,2007,42(5):325-329. 被引量:22
  • 3Han xiaohong, et al. Oncancer muhidrugresistance reversal[ J]. Jour- nal of Bei Hua University( National Science) ,2005,6 (1):36 -37.
  • 4Nakopoulou L, Lzaris AC, Kavantzas N, et al. DNA Topoisomerase II - alpha jmmunoreactivity as a maker of tumor aggressiveness in in- vasive breast cancer[J]. Pathobiology,2000,68(3): 137 -143.
  • 5Wjllman JH, Holden JA. Immunohistoehemicalstaining for DNA To- poisomerase II - alpha in benign, premalignant, and malignant lesions of the prostate [ J ]. Prostate,2000,42 (4) : 280 - 286.
  • 6Stathopoulos GP, Kapranos N, Mnolopoulos L, et al. Topoisomera- selI- alpha expression in squamous cell carcinomas of the head and neck[ J]. Anticancer Res,2000,20: 177 -182.
  • 7Brustmann H. Expressionof cellular apoptosis susceptibility protein in serous ovarian carcinoma:a clinicopathologic and immunohistochemi- cal study [ J ]. Gynecol Once1,2004,92 ( 1 ) : 268 -276.
  • 8LI J, YEN C, LIAW D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer [ J ]. Science, 1997,275 (28) : 1943 - 1947.
  • 9] Wu H, Wang S, Weng I), et al. Reversal of the malignant pheno- type of ovarian cancer A2750 cells through transfection with wild - type PTEN gene[J]. Cancer Lett,2008,271 (2) : 205 -214.
  • 10李锁严,杨薇薇,温秋婷,徐丽,孟红梅,陈明,陈鹤.PTEN和HIF-1α在卵巢浆液性肿瘤中的表达及其相关性的研究[J].赤峰学院学报(自然科学版),2009,25(9):99-101. 被引量:2

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部